Literature DB >> 10610356

Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin.

D Nath1, A Hartnell, L Happerfield, D W Miles, J Burchell, J Taylor-Papadimitriou, P R Crocker.   

Abstract

In many carcinomas, infiltrating macrophages are commonly found closely associated with tumour cells but little is known concerning the nature or significance of adhesion molecules involved in these cellular interactions. Here we demonstrate in primary human breast cancers that sialoadhesin (Sn), a macrophage-restricted adhesion molecule, is frequently expressed on infiltrating cells that often make close contact with breast carcinoma cells. To determine whether Sn could act as a specific receptor for ligands on breast cancer cell lines, binding assays were performed with a recombinant form of the protein fused to the Fc portion of human immunoglobulin G1 (IgG1) (Sn-Fc). Sn-Fc was found to bind specifically and in a sialic acid-dependent manner to the breast cancer cell lines MCF-7, T47.D and BT-20 both in solid- and solution-phase binding assays. To investigate the nature of the sialoglycoproteins recognized by Sn on breast cancer cells, MCF-7 cells were labelled with [6-3H]glucosamine. Following precipitation with Sn-Fc, a major band of approximately 240000 MW was revealed, which was shown in reprecipitation and Western blotting experiments to be the epithelial mucin, MUC1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10610356      PMCID: PMC2326916          DOI: 10.1046/j.1365-2567.1999.00827.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

2.  Antibodies to the cytoplasmic domain of the MUC1 mucin show conservation throughout mammals.

Authors:  L Pemberton; J Taylor-Papadimitriou; S J Gendler
Journal:  Biochem Biophys Res Commun       Date:  1992-05-29       Impact factor: 3.575

Review 3.  Tumour-associated leucocytes: friends or foes in breast carcinoma.

Authors:  C O'Sullivan; C E Lewis
Journal:  J Pathol       Date:  1994-03       Impact factor: 7.996

4.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

Authors:  E van de Wiel-van Kemenade; M J Ligtenberg; A J de Boer; F Buijs; H L Vos; C J Melief; J Hilkens; C G Figdor
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

5.  The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.

Authors:  D Nath; P A van der Merwe; S Kelm; P Bradfield; P R Crocker
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

6.  Secretion of epidermal growth factor by macrophages associated with breast carcinoma.

Authors:  C O'Sullivan; C E Lewis; A L Harris; J O McGee
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

7.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.

Authors:  I Brockhausen; J M Yang; J Burchell; C Whitehouse; J Taylor-Papadimitriou
Journal:  Eur J Biochem       Date:  1995-10-15

8.  Delayed mammary tumor progression in Muc-1 null mice.

Authors:  A P Spicer; G J Rowse; T K Lidner; S J Gendler
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

9.  Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains.

Authors:  P R Crocker; S Mucklow; V Bouckson; A McWilliam; A C Willis; S Gordon; G Milon; S Kelm; P Bradfield
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

10.  Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule.

Authors:  T K van den Berg; J J Brevé; J G Damoiseaux; E A Döpp; S Kelm; P R Crocker; C D Dijkstra; G Kraal
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Siglecs in the immune system.

Authors:  P R Crocker; A Varki
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

Review 2.  Tumor-associated macrophages in breast cancer.

Authors:  Russell D Leek; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

3.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Authors:  Isabel Correa; Tim Plunkett; Anda Vlad; Arron Mungul; Jessica Candelora-Kettel; Joy M Burchell; Joyce Taylor-Papadimitriou; Olivera J Finn
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

Review 4.  Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

Authors:  Seema Chugh; Vinayaga S Gnanapragassam; Maneesh Jain; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2015-08-28

5.  The inhibitory potencies of monoclonal antibodies to the macrophage adhesion molecule sialoadhesin are greatly increased following PEGylation.

Authors:  Julie Ducreux; Rita Vanbever; Paul R Crocker
Journal:  Bioconjug Chem       Date:  2008-09-23       Impact factor: 4.774

Review 6.  MUC1 (CD227): a multi-tasked molecule.

Authors:  Vasso Apostolopoulos; Lily Stojanovska; Sharron E Gargosky
Journal:  Cell Mol Life Sci       Date:  2015-08-21       Impact factor: 9.261

Review 7.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.

Authors:  Takumi Kiwamoto; Toshihiko Katoh; Michael Tiemeyer; Bruce S Bochner; Christopher M Evans; William J Janssen; Mary E Brummet; Sherry A Hudson; Zhou Zhu
Journal:  J Allergy Clin Immunol       Date:  2014-12-12       Impact factor: 10.793

9.  Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.

Authors:  Shuhei Tanida; Kaoru Akita; Akiko Ishida; Yugo Mori; Munetoyo Toda; Mizue Inoue; Mariko Ohta; Masakazu Yashiro; Tetsuji Sawada; Kosei Hirakawa; Hiroshi Nakada
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

10.  Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Authors:  Jennifer A Belisle; Sachi Horibata; Gubbels A A Jennifer; Sarah Petrie; Arvinder Kapur; Sabine André; Hans-Joachim Gabius; Claudine Rancourt; Joseph Connor; James C Paulson; Manish S Patankar
Journal:  Mol Cancer       Date:  2010-05-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.